Cargando…

Comparison of Elixhauser and Charlson Methods for Predicting Oral Cancer Survival

Cancer survival correlates not only with the features of primary malignancy but also with the degree of underlying comorbidities. Of the multiple methods used for evaluating the impact of comorbidities on survival, the Charlson and Elixhauser methods are most common. This study compared these 2 como...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Heng-Jui, Chen, Po-Chun, Yang, Ching-Chieh, Su, Yu-Chieh, Lee, Ching-Chih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998653/ https://www.ncbi.nlm.nih.gov/pubmed/26886653 http://dx.doi.org/10.1097/MD.0000000000002861

Ejemplares similares

Age-Adjusted Charlson Comorbidity Index Scores as Predictor of Survival in Colorectal Cancer Patients Who Underwent Surgical Resection and Chemoradiation
por: Wu, Chin-Chia, et al.
Publicado: (2015)

Comparison of Elixhauser and Charlson Methods for Discriminative Performance in Mortality Risk in Patients with Schizophrenic Disorders
por: Tsai, Kuan-Yi, et al.
Publicado: (2020)

A Comparison of the Charlson and Elixhauser Methods for Predicting Nursing Indicators in Gastrectomy with Gastric Cancer Patients
por: Kim, Chul-Gyu, et al.
Publicado: (2023)

Modified Tumor Classification With Inclusion of Tumor Characteristics Improves Discrimination and Prediction Accuracy in Oral and Hypopharyngeal Cancer Patients Who Underwent Surgery
por: Lee, Ching-Chih, et al.
Publicado: (2015)

Determinants for Aggressive End-of-Life Care for Oral Cancer Patients: A Population-Based Study in an Asian Country
por: Chang, Ting-Shou, et al.
Publicado: (2015)

National Norms for the Elixhauser and Charlson Comorbidity Indexes Among Hospitalized Adults
por: Loyd, Christine, et al.
Publicado: (2021)

Coding algorithms for defining Charlson and Elixhauser co-morbidities in Read-coded databases
por: Metcalfe, David, et al.
Publicado: (2019)

Comparing the Performance of Charlson and Elixhauser Comorbidity Indices to Predict In-Hospital Mortality Among a Chinese Population
por: Cai, Miao, et al.
Publicado: (2020)

The Prognostic Ability of Log Odds of Positive Lymph Nodes in Oral Cavity Squamous Cell Carcinoma
por: Lee, Ching-Chih, et al.
Publicado: (2015)

High neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio predict poor survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy
por: Ke, Te-Min, et al.
Publicado: (2020)

Prognosis models for severe and critical COVID-19 based on the Charlson and Elixhauser comorbidity indices
por: Zhou, Wei, et al.
Publicado: (2020)

Simple Excel and ICD-10 based dataset calculator for the Charlson and Elixhauser comorbidity indices
por: Prommik, Pärt, et al.
Publicado: (2022)

Performance of Charlson and Elixhauser Comorbidity Index to Predict in-Hospital Mortality in Patients with Stroke in Sumadija and Western Serbia
por: Bajic, Biljana, et al.
Publicado: (2021)

The Deyo-Charlson and Elixhauser-van Walraven Comorbidity Indices as predictors of mortality in critically ill patients
por: Ladha, Karim S, et al.
Publicado: (2015)

The association between the composite quality measure “textbook outcome” and long term survival in operated colon cancer
por: Yang, Ching-Chieh, et al.
Publicado: (2020)

Comparison of the performance of the CMS Hierarchical Condition Category (CMS-HCC) risk adjuster with the charlson and elixhauser comorbidity measures in predicting mortality
por: Li, Pengxiang, et al.
Publicado: (2010)

Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction
por: Snow, Gregory L., et al.
Publicado: (2020)

Comparing Charlson and Elixhauser comorbidity indices with different weightings to predict in-hospital mortality: an analysis of national inpatient data
por: Sharma, Narayan, et al.
Publicado: (2021)

Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases
por: Li, Bing, et al.
Publicado: (2008)

Comorbidity and thirty-day hospital readmission odds in chronic obstructive pulmonary disease: a comparison of the Charlson and Elixhauser comorbidity indices
por: Buhr, Russell G., et al.
Publicado: (2019)

Survival Prediction Model Using Clinico-Pathologic Characteristics for Nonsmall Cell Lung Cancer Patients After Curative Resection
por: Wu, Ching-Yang, et al.
Publicado: (2015)

Validity of the Age-Adjusted Charlson Comorbidity Index on Clinical Outcomes for Patients with Nasopharyngeal Cancer Post Radiation Treatment: A 5-Year Nationwide Cohort Study
por: Yang, Ching-Chieh, et al.
Publicado: (2015)

Deltoid Branch of Thoracoacromial Vein: A Safe Alternative Entry Vessel for Intravenous Port Implantation
por: Su, Ta-Wei, et al.
Publicado: (2015)

Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan
por: Chen, Hui-Shan, et al.
Publicado: (2016)

Discriminative Ability for Adverse Outcomes in Traumatic Ankle Fracture: A Comparison of the Modified Charlson Comorbidity Index, Elixhauser Comorbidity Measure, and Modified Frailty Index
por: Mehta, Sanket, et al.
Publicado: (2022)

Long-Term Survival in Patients With T2 Hepatocellular Carcinoma After Primary Curative Resection Can Be Further Stratified by Tumor Size
por: Ho, Cheng-Maw, et al.
Publicado: (2014)

Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma
por: Kuo, Hsing-Tao, et al.
Publicado: (2017)

Adjusted Age-Adjusted Charlson Comorbidity Index Score as a Risk Measure of Perioperative Mortality before Cancer Surgery
por: Chang, Chun-Ming, et al.
Publicado: (2016)

Esophageal neuroendocrine tumor with initial presentation as painless forehead and neck masses: A case report
por: Chin, Yen-Po, et al.
Publicado: (2017)

Pathologic Stage of Nonsmall Cell Lung Cancer Patients Presenting as Resectable Cases After Neoadjuvant Therapy Did Not Predict the Prognosis
por: Wu, Ching-Yang, et al.
Publicado: (2015)

Correction: Adjusted Age-Adjusted Charlson Comorbidity Index Score as a Risk Measure of Perioperative Mortality before Cancer Surgery
por: Chang, Chun-Ming, et al.
Publicado: (2016)

Comparing co-morbidities in total joint arthroplasty patients using the RxRisk-V, Elixhauser, and Charlson Measures: a cross-sectional evaluation
por: Inacio, Maria C. S., et al.
Publicado: (2015)

Comparing Treatment Plan in All Locations of Esophageal Cancer: Volumetric Modulated Arc Therapy versus Intensity-Modulated Radiotherapy
por: Lin, Jang-Chun, et al.
Publicado: (2015)

Prediction Ability of Charlson, Elixhauser, and Rx-Risk Comorbidity Indices for Mortality in Patients with Hip Fracture. A Danish Population-Based Cohort Study from 2014 – 2018
por: Vesterager, Jeppe Damgren, et al.
Publicado: (2022)

Treatment outcomes of primary surgery versus chemoradiotherapy for T4 oropharyngeal cancers
por: Yen, Ching-Heng, et al.
Publicado: (2022)

A Simple Risk Model to Predict Survival in Patients With Carcinoma of Unknown Primary Origin
por: Huang, Chen-Yang, et al.
Publicado: (2015)

Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer
por: Yang, Po-Chih, et al.
Publicado: (2016)

The Ability of Comorbidity Indices to Predict Mortality After Heart Transplantation: A Validation of the Danish Comorbidity Index for Acute Myocardial Infarction, Charlson Comorbidity Index, and Elixhauser Comorbidity Index
por: Bonnesen, Kasper, et al.
Publicado: (2023)

Brain MRI imaging characteristics predict treatment response and outcome in patients with de novo brain metastasis of EGFR-mutated NSCLC
por: Lin, Chia-Ying, et al.
Publicado: (2019)

A high density of PD-L1-expressing immune cells is significantly correlated with favorable disease free survival in nonmetastatic colorectal cancer
por: Kuo, Ya-Ting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hgpplhl7d3gv0tqhnqfq28sodm